Objectives: To evaluate the prevalence and the factors associated with recurrence of
myasthenia gravis following thymectomy. Methods: Six electronic databases which reported …

OBJECTIVES Thymectomy is the treatment of choice for thymomatous myasthenia gravis
(MG) for both oncological and neurological aspects. However, only a few studies comprising …

Thymectomy has become an increasingly popular procedure for myasthenia gravis.
Knowledge of factors associated with a good outcome (remission) or those most likely to …

Background Myasthenia gravis is an autoimmune neuromuscular disorder characterized by
the production of abnormal autoantibodies directed against the receptors present in the …

This study aimed to reveal the clinical course and outcomes of myasthenia gravis (MG) in
patients with thymic lymphoid hyperplasia and thymoma undergoing extended thymectomy …

Background: The purpose of the study was to determine the risk factors of post-surgery
myasthenia crisis (PMC) among myasthenia gravis (MG) patients. Methods: A meta-analysis …

Purpose: Thymectomy is the first-line therapy for thymomatous myasthenia gravis patients.
The aim of this study is to explore the clinical outcome and predictors of postoperative …

Background The length of time for clinical improvement of patients with thymomatous
myasthenia gravis (MG) after extended thymectomy is not clear. The purpose of this study …

OBJECTIVES: This study aims to investigate whether thymectomy is beneficial for late-onset
(> 50 years) myasthenia gravis patients with no thymoma, particularly for those with mild …

Thymectomy is considered a therapeutic option for patients with myasthenia gravis. A
myasthenic patient who has not received any treatment for years and shows no signs or …